Liu et al. [48] reported that the efficacy of platinum-based chemotherapy in NSCLC decreased with the increasing ratio of FOXP3+ Treg and CD8+ T, suggesting the abundance of eTregs in tumor sites was an independent factor for poor response to platinum-based chemotherapy. This evidence concerns the gene FOXP3 and neoplasm.